Abstract:A biofilm is a community of stable microorganisms encapsulated in an extracellular matrix produced by themselves. Many types of microorganisms that are found on living hosts or in the environment can form biofilms. These include pathogenic bacteria that can serve as a reservoir for persistent infections, and are culpable for leading to a broad spectrum of chronic illnesses and emergence of antibiotic resistance making them difficult to be treated. The absence of biofilm-targeting antibiotics in the drug discovery pipeline indicates an unmet opportunity for designing new biofilm inhibitors as antimicrobial agents using various strategies and targeting distinct stages of biofilm formation. The strategies available to control biofilm formation include targeting the enzymes and proteins specific to the microorganism and those involved in the adhesion pathways leading to formation of resistant biofilms. This review primarily focuses on the recent strategies and advances responsible for identifying a myriad of antibiofilm agents and their mechanism of biofilm inhibition, including extracellular polymeric substance synthesis inhibitors, adhesion inhibitors, quorum sensing inhibitors, efflux pump inhibitors, and cyclic diguanylate inhibitors. Furthermore, we present the structure–activity relationships (SAR) of these agents, including recently discovered biofilm inhibitors, nature-derived bioactive scaffolds, synthetic small molecules, antimicrobial peptides, bioactive compounds isolated from fungi, non-proteinogenic amino acids and antibiotics. We hope to fuel interest and focus research efforts on the development of agents targeting the uniquely complex, physical and chemical heterogeneous biofilms through a multipronged approach and combinatorial therapeutics for a more effective control and management of biofilms across diseases.

Emerging peptide-based technology for biofilm control

The Development of a Pipeline for the Identification and Validation of Small-Molecule RelA Inhibitors for Use as Anti-Biofilm Drugs.

Antimicrobial Peptides Against Microbial Biofilms: Efficacy, Challenges, and Future Prospect

Promising strategies for future treatment of Klebsiella pneumoniae biofilms.

Emerging strategies for treating medical device and wound-associated biofilm infections

Understanding the intricacies of microbial biofilm formation and its endurance in chronic infections: a key to advancing biofilm-targeted therapeutic strategies

Biofilm-mediated infections by multidrug-resistant microbes: a comprehensive exploration and forward perspectives

Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance

Beyond the Risk of Biofilms: An Up-and-Coming Battleground of Bacterial Life and Potential Antibiofilm Agents

Current Strategies for Combating Biofilm-Forming Pathogens in Clinical Healthcare-Associated Infections

Recent advances in nanotechnology for eradicating bacterial biofilm

Antibiofilm Peptides and Peptidomimetics with Focus on Surface Immobilization

Bacteriophage-Mediated Control of Biofilm: A Promising New Dawn for the Future

Non-antibiotic antimicrobial agents to combat biofilm-forming bacteria

Novel Approaches to Combat Medical Device-Associated BioFilms

Advancing Anti‐Biofilm Strategies: Innovations to Combat Biofilm‐Related Challenges and Enhance Efficacy

Novel Strategies for the Prevention and Treatment of Biofilm Related Infections

Pseudomonas aeruginosa Biofilm Formation and Its Control

Promising Therapeutic Strategies Against Microbial Biofilm Challenges

Bacteriophage-mediated approaches for biofilm control

Bacterial Biofilm Inhibition: A Focused Review on Recent Therapeutic Strategies for Combating the Biofilm Mediated Infections